rheumatoid arthritis therapy (Japan Energy)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namerheumatoid arthritis therapy (Japan Energy)
Drug Alias Namequinazoline derivatives (Japan Energy)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTNF alpha synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Energy Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJapan Energy Corp
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A